2026-2030年全球抗藥性金黃色葡萄球菌（MRSA）檢測市場

全球抗藥性金黃色葡萄球菌(MRSA) 檢測市場預計將從 2025 年到 2030 年成長至 11.584 億美元，預測期內複合年成長率為 14.1%。

這份關於全球抗藥性金黃色葡萄球菌(MRSA) 檢測市場的報告提供了全面的分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：醫院感染病例增加、強制性患者篩檢、快速照護現場分子診斷技術的創新，以及全球日益重視合理使用抗生素和預防抗菌素抗藥性。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模數據、細分市場數據及區域分析，以及供應商格局數據。此外，報告還包含歷史數據和預測數據。

本研究指出，自動化多重檢測和次世代定序技術的整合是未來幾年全球抗藥性金黃色葡萄球菌（MRSA）檢測市場成長的關鍵促進因素。此外，人工智慧和機器學習在診斷流程中的應用，以及分散式和門診篩檢模式在醫院以外的擴展，預計也將產生巨大的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球抗藥性金黃色葡萄球菌（MRSA）檢測市場
• 2020年至2024年最終用戶細分市場分析
• 按類型分類的細分市場分析，2020-2024 年
• 產品類型細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球抗藥性金黃色葡萄球菌(MRSA) 檢測市場
• 地緣政治衝突的影響：全球抗藥性金黃色葡萄球菌(MRSA) 檢測市場。

第7章：五力分析

第8章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院/診斷檢查室
• 學術研究機構
• 市場機會：依最終用戶分類

第9章 市場細分：依類型

• 比較：按類型
• 分子診斷
• 免疫診斷
• 市場機會：按類型分類

第10章 市場區隔：依產品類型

• 比較：依產品類型
• 試劑和試劑盒
• 裝置
• 市場機會：依產品類型分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • 土耳其
  • 南非
  • UAE
  • 阿根廷
  • 哥倫比亞
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Autobio Diagnostics Co. Ltd.
• Beckman Coulter Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• BioMerieux SA
• Bruker Corp.
• DiaSorin SpA
• F. Hoffmann La Roche Ltd.
• HiMedia Laboratories Pvt. Ltd.
• Hologic Inc.
• Meridian Bioscience Inc.
• QIAGEN NV
• QuidelOrtho Corp.
• R Biopharm AG
• Thermo Fisher Scientific Inc.

第16章附錄

The global methicillin-resistant staphylococcus aureus (MRSA) testing market is forecasted to grow by USD 1158.4 mn during 2025-2030, accelerating at a CAGR of 14.1% during the forecast period. The report on the global methicillin-resistant staphylococcus aureus (MRSA) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising hospital-acquired infections and mandatory patient screening policies, technological innovations in rapid point-of-care molecular diagnostics, growing global emphasis on antibiotic stewardship and antimicrobial resistance prevention.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global methicillin-resistant staphylococcus aureus (MRSA) testing market is segmented as below:

By End-User

• Hospitals and diagnostic laboratories
• Academic and research institutes

By Type

• Molecular diagnostics
• Immunodiagnostics

By Product Type

• Reagents and kits
• Instruments

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the transition toward automated multiplexing and next-generation sequencing integration as one of the prime reasons driving the global methicillin-resistant staphylococcus aureus (mrsa) testing market growth during the next few years. Also, integration of ai and ml in diagnostic workflows and expansion of decentralized and outpatient screening models beyond hospital settings will lead to sizable demand in the market.

The report on the global methicillin-resistant staphylococcus aureus (mrsa) testing market covers the following areas:

• Global methicillin-resistant staphylococcus aureus (mrsa) testing market sizing
• Global methicillin-resistant staphylococcus aureus (mrsa) testing market forecast
• Global methicillin-resistant staphylococcus aureus (mrsa) testing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global methicillin-resistant staphylococcus aureus (mrsa) testing market vendors that include Autobio Diagnostics Co. Ltd., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Bruker Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hardy Diagnostics, HiMedia Laboratories Pvt. Ltd., Hologic Inc., LABORATORIOS CONDA S.A, Liofilchem Srl, Meridian Bioscience Inc., QIAGEN N.V., QuidelOrtho Corp., R Biopharm AG, Seegene Inc., Thermo Fisher Scientific Inc.. Also, the global methicillin-resistant staphylococcus aureus (mrsa) testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market 2020 - 2024
  • Historic Market Size - Data Table on Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.4 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global methicillin-resistant staphylococcus aureus (MRSA) testing market
• 6.2 Impact of geopolitical conflicts on global methicillin-resistant staphylococcus aureus (MRSA) testing market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 Hospitals and diagnostic laboratories - Market size and forecast 2025-2030
• 8.4 Academic and research institutes - Market size and forecast 2025-2030
• 8.5 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Type

• 9.1 Market segments
• 9.2 Comparison by Type
• 9.3 Molecular diagnostics - Market size and forecast 2025-2030
• 9.4 Immunodiagnostics - Market size and forecast 2025-2030
• 9.5 Market opportunity by Type
  • Market opportunity by Type ($ million)

10 Market Segmentation by Product Type

• 10.1 Market segments
• 10.2 Comparison by Product Type
• 10.3 Reagents and kits - Market size and forecast 2025-2030
• 10.4 Instruments - Market size and forecast 2025-2030
• 10.5 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 Turkey - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 UAE - Market size and forecast 2025-2030
  • 12.6.6 Argentina - Market size and forecast 2025-2030
  • 12.6.7 Colombia - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising hospital-acquired infections and mandatory patient screening policies
  • Technological innovations in rapid point-of-care molecular diagnostics
  • Growing global emphasis on antibiotic stewardship and antimicrobial resistance prevention
• 13.2 Market challenges
  • High capital expenditure and infrastructure limitations in resource-constrained regions
  • Diagnostic ambiguity and false results driven by genetic heterogeneity
  • Shortage of specialized laboratory technicians and operational workforce constraints
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Transition toward automated multiplexing and next-generation sequencing integration
  • Integration of AI and ML in diagnostic workflows
  • Expansion of decentralized and outpatient screening models beyond hospital settings

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Autobio Diagnostics Co. Ltd.
  • Autobio Diagnostics Co. Ltd. - Overview
  • Autobio Diagnostics Co. Ltd. - Product / Service
  • Autobio Diagnostics Co. Ltd. - Key offerings
  • SWOT
• 15.5 Beckman Coulter Inc.
  • Beckman Coulter Inc. - Overview
  • Beckman Coulter Inc. - Product / Service
  • Beckman Coulter Inc. - Key offerings
  • SWOT
• 15.6 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.7 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.8 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 15.9 Bruker Corp.
  • Bruker Corp. - Overview
  • Bruker Corp. - Business segments
  • Bruker Corp. - Key offerings
  • Bruker Corp. - Segment focus
  • SWOT
• 15.10 DiaSorin SpA
  • DiaSorin SpA - Overview
  • DiaSorin SpA - Business segments
  • DiaSorin SpA - Key news
  • DiaSorin SpA - Key offerings
  • DiaSorin SpA - Segment focus
  • SWOT
• 15.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.12 HiMedia Laboratories Pvt. Ltd.
  • HiMedia Laboratories Pvt. Ltd. - Overview
  • HiMedia Laboratories Pvt. Ltd. - Product / Service
  • HiMedia Laboratories Pvt. Ltd. - Key offerings
  • SWOT
• 15.13 Hologic Inc.
  • Hologic Inc. - Overview
  • Hologic Inc. - Product / Service
  • Hologic Inc. - Key offerings
  • SWOT
• 15.14 Meridian Bioscience Inc.
  • Meridian Bioscience Inc. - Overview
  • Meridian Bioscience Inc. - Product / Service
  • Meridian Bioscience Inc. - Key offerings
  • SWOT
• 15.15 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key offerings
  • SWOT
• 15.16 QuidelOrtho Corp.
  • QuidelOrtho Corp. - Overview
  • QuidelOrtho Corp. - Business segments
  • QuidelOrtho Corp. - Key offerings
  • QuidelOrtho Corp. - Segment focus
  • SWOT
• 15.17 R Biopharm AG
  • R Biopharm AG - Overview
  • R Biopharm AG - Product / Service
  • R Biopharm AG - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations